Samar Alanazi

4PUBLICATIONS
4CO-AUTHORS
Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 18, 2023
HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers.

Samar M Alanazi, Wasim Feroz, Rosalin Mishra

|Dec 23, 2022
HER3 Alterations in Cancer and Potential Clinical Implications.

Mary Kate Kilroy, SoYoung Park, Wasim Feroz

|Nov 27, 2021
IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma.

Hima Patel, Rosalin Mishra, Nour Yacoub

|Apr 03, 2021
PI3K Inhibitors in Cancer: Clinical Implications and Adverse Effects.

Rosalin Mishra, Hima Patel, Samar Alanazi

Pageof 1